J. Goldman & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-193,313
| Closed | -$587K | – | 282 |
|
|
2018
Q4 | $587K | Buy |
193,313
+66,213
| +52% | +$201K | 0.05% | 136 |
|
|
2018
Q3 | $533K | Hold |
127,100
| – | – | 0.04% | 129 |
|
|
2018
Q2 | $491K | Buy |
+127,100
| New | +$491K | 0.03% | 180 |
|
|
2017
Q3 | – | Sell |
-33,905
| Closed | -$331K | – | 332 |
|
|
2017
Q2 | $331K | Buy |
+33,905
| New | +$331K | 0.02% | 155 |
|